August 7th 2025, 5:00pm
I survived peritoneal mesothelioma thanks to the love, prayers, and support of family, friends, and strangers who reminded me I was never alone.
August 7th 2025, 4:00pm
In a phase 3 trial, 72.2% of patients with recurrent low-grade bladder cancer kept complete response at 24 months after Zusduri treatment.
August 7th 2025, 3:00pm
An artificial intelligence-based image analysis model has more accurately predicted cancer biomarkers and outcomes compared with conventional methods.
August 7th 2025, 1:00pm
Getting an expert opinion is essential after a rare cancer diagnosis like GIST, as each patient’s situation is unique, according to Dr. Weijing Sun.
August 6th 2025, 9:00pm
Staci Kirk, a six-time cancer survivor, founded the Stiletto Boss Foundation to empower women through mentorship, self-advocacy and healing.
August 6th 2025, 8:00pm
In an interview with CURE, Clara Cirks shares the emotional weight of finishing chemo while facing ongoing immunotherapy and the uncertainty it brings.
August 6th 2025, 6:55pm
The U.S. FDA granted accelerated approval to Modeyso for patients with diffuse midline glioma with an H3 K27M mutation with progressive disease.
August 6th 2025, 5:00pm
Following the June 2025 FDA approval of Datroway, Dr. Jacob A. Sands explained the significance of the regulatory approval for patients with lung cancer.
August 6th 2025, 4:00pm
During my breast cancer journey, my sister Kelly’s love and support — especially the day she shaved my head — gave me strength, comfort, and control.
August 6th 2025, 2:55pm
The FDA accepted a supplemental application for Breyanzi to treat adults with relapsed or refractory marginal zone lymphoma after two prior therapies.
Trodelvy Misses Primary Endpoint in ASCENT-07 Breast Cancer Trial
Shining a Light on Pancreatic Cancer Progress and Support
Barbie, Breast Cancer and the Power of Dolls in Healing
Myeloma Advocate Stresses Support for Caregivers in Black Community